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The present study was conducted to fabricate a 3D scaffold using polycaprolactone (PCL) and silicate based bioactive glass-ceramic
(R-SBgC).Different concentrations of R-SBgCprepared from rice husk ash (RHA)were combinedwith PCL to fabricate a composite
scaffold using thermally induced phase separation (TIPS) method. The products were then characterized using SEM and EDX.
The results demonstrated that R-SBgC in PCL matrix produced a bioactive material which has highly porous structure with
interconnected porosities.There appears to be a relationship between the increase in R-SBgC concentration and increased material
density and compressive modulus; however, increasing R-SBgC concentration result in reduced scaffold porosity. In conclusion, it
is possible to fabricate a PCL/bioactive glass-ceramic composite from processed rice husk. Varying the R-SBgC concentrations can
control the properties of this material, which is useful in the development of the ideal scaffold intended for use as a bone substitute
in nonload bearing sites.
1. Introduction
The use of biomaterials for treating bone defects has been
widely accepted despite the availability of natural bone grafts.
This is due to the lack of donor site morbidity issues and
the avoidance of possible disease transmission regarding
biomaterials [1–3]. Among the many biomaterials available,
polycaprolactone (PCL), which is a synthetic biodegradable
polymer, has shown great promise [4, 5]. In fact, PCL is
presently one of the few biomaterials approved by FDA
for use as bone graft substitutes [5–7]. PCL can be easily
fabricated into a material possessing the desired toughness,
which is appropriate for bone replacement. In addition to
being biocompatible, PCL has a low degradation rate, which
is a desired feature in a biomaterial designed for specific
sites of bone with longer healing times [4]. However, this
material alone without additives demonstrates low mechan-
ical resistance to compressive loading, hydrophobicity, and
low bioactivity [8]. To counter these problems, bioactive
ceramics/biodegradable polymer composite materials were
introduced. These new materials demonstrated superior
properties including improvement in material strength, stiff-
ness, biodegradability, osteoconductivity, and bioactivity [4,
6, 7, 9]. In addition, polymer/bioactive ceramic compos-
ite scaffolds have structures that resemble bone, where
the inorganic component of these scaffolds mimics the
hydroxycarbonate-apatite (HCA) motifs while the polymer
component mimics the collagen-rich extracellular matrix.
Although both HCA and bioactive glasses have been used to
form composites with superior bioactivity, bioactive glasses
have been preferred due to their superior osteoconductive
properties [10, 11]. Furthermore, not only do bioactive glasses
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increase the hydrophilicity but they also increase the hydrol-
ysis of PCL, thereby increasing the composites degradation
rate, albeit at a control rate sufficient for creeping substitution
to occur [4, 5, 12–15]. Along with other Added features such
as improved porosity with interconnectivity of the pores in
this composite, such a product will be of great value for use in
clinical applications. A method by which increased porosity
can be achieved is adopting thermally induced phase separa-
tion technique (TIPS) [16]. Despite its many advantages, the
fabrication of such composites has not been widely described
in the literature.We therefore conducted a study to determine
if R-SBgC made from rice husk, which is an abundant plant
waste produced in most parts of the world, can be fabricated
to become a composite PCL scaffold with the desired proper-
ties required for use as a potential bone substitute.
2. Materials and Methods
2.1.Materials Preparation. PCL (molecularweight of 70,000–
90,000) was purchased from Sigma Aldrich. Analytical grade
1, 4-Dioxane was used as a solvent (Sigma Aldrich.). The R-
SBgC was synthesized by sol-gel method using RHA with
the composition of (mol%) 50SiO
2
⋅25Na
2
O⋅25CaO [17]. Rice
husk was obtained from Kahang Organic Rice Eco Farm
in Johor and after washing and drying in a hot air oven
overnight, it was heat treated in 650∘C to achieve RHA with
98% pure Silica [17, 18]. Sol preparation involved mixing ade-
quate amounts of distilled water, NaOH pellets (Merck.), and
RHA. This was done under stirring condition, until a clear
solution was obtained.This Process generally takes about one
hour. Acidic solutions of HNO
3
(2N) with CaNO
3
⋅4H
2
O (all
Merck.) were mixed separately. The prepared sodium silicate
solution was slowly added to the acidic solution until the
gelling process was completed. The gel was allowed to age
and dry, and later it was left in the furnace to sinter for 1
hour at 600∘C. Lastly, the product was crushed to obtain the
R-SBgC in the powder form. The amorphous and partially
crystallized phases of R-SBgC were confirmed using X-ray
diffraction (XRD) through CuK𝛼 radiation (Rigaku Geiger-
flexDmax-C). To achieve homogenous nanosized particles in
the powder, the dried and sintered R-SBgC was freeze-dried
using the proper related apparatus (LABCONCO-Freeze dry
system, USA).
2.2. Scaffold Fabrication. The TIPS technique was utilized
to fabricate R-SBgC/PCL composite scaffold as shown in
Figure 1. 15mL of 1, 4 Dioxane was used to dissolve 1 g
of PCL polymer granules (PCL concentration %6.6 (w/v)).
The R-SBgC was dispersed in the polymer solution in 10%,
20%, and 30% (w/w) and homogenized using a hand-held
homogenizer. The polymer/R-SBgC solutions as well as the
pure PCL solution were poured in separate glass vials and
stored in a −18∘C freezer. After overnight freezing, the
materials were placed in a freeze-dryer for 48 hours subjected
to −45∘C and 0.012 mbar pressure in order to eliminate
the solvent. The obtained materials were then left at room
temperature for 24 hours.
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Figure 1: Schematic diagram of the scaffold production.
2.2.1. Characterization Using SEM and FESEM and EDX
before and after Bioactivity Testing. To study the morphology
of the composite scaffolds, scanning electron microscopy
(SEM; Hitachi, TM 3000) and field emission scanning
electron microscopy (FESEM; Carls Zeiss 35 VP Supra,
Germany) were employed with acceleration voltages of 15 kV
and 20 kV, respectively. After freezing for 24 hours at −18∘C,
the materials were cut into desired shapes. Specimens were
sputter-coated with a thin layer of gold prior to SEM. Energy
dispersive X-ray spectroscopy (EDX; Carls Zeiss 35VP Supra,
Germany) was utilized to ascertain the presence of R-SBgC
nanoparticles distribution in PCLmatrix and hydroxy apatite
(HA) formation. Testingwas done before and after bioactivity
testing to determine structural changes as a result of the
simulated bioactivity in vitro.
2.2.2. Determination of Density and Porosity. The density
and porosity of the polymeric foams were measured using
liquid displacement method [19]. Usually, water is used as the
displacement liquid. However, in the present study, ethanol
was instead utilized because (1) ethanol, like water, does
not dissolve PCL and (2) ethanol has the ability to infiltrate
into the pores more easily without causing any shrinkage or
swelling effects on the scaffolds.
Measurement for density and porosity of the scaffolds
are described as follows. The Scaffold sample (weight = 𝑊)
was immersed in a graduated cylinder containing a known
volume of ethanol (𝑉
1
) for 15min. The total volume of
ethanol and the ethanol-impregnated scaffold was referred to
as 𝑉
2
and the remaining volume of ethanol after removing
impregnated scaffold was labeled𝑉
3
.The scaffold volumewas
obtained by subtracting 𝑉
2
from 𝑉
1
. The volume difference
between𝑉
1
and𝑉
3
indicates the volume of ethanol held inside
the foams. The total volume of the foam is expressed as
𝑉 = (𝑉
2
− 𝑉
1
) + (𝑉
1
− 𝑉
3
) = 𝑉
2
− 𝑉
3
. (1)
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Figure 2: Physical appearance of R-SBgC/PCL scaffolds.
Whilst the density of the foam is
𝑑 =
𝑊
(𝑉
2
− 𝑉
3
)
, (2)
and porosity is
𝑃 =
(𝑉
1
− 𝑉
3
)
(𝑉
2
− 𝑉
3
)
. (3)
Equations (1), (2), and (3) were used for calculating the
density and porosity.The calculated results are presented as a
mean ± standard deviation (SD) for each group of scaffolds.
To determine the pore size, the average of measurements
using SEM images of 25 randompores from each scaffold was
calculated.
2.2.3. Capillarity Test. The scaffold permeability was deter-
mined by performing capillarity test. The fluid infiltrated the
interconnected pores due to the capillarity effect. For this
assessment, a lean slice of composite scaffold (1mm thick)
was placed into a solution with a viscosity similar to that of
human blood. The solution colored by adding some drops of
bluish purple ink helps track the fluid movement.
2.2.4. Compression Mechanical Test. To evaluate the com-
pressive mechanical properties of the composite scaffolds, a
universal testing machine (Instron 5982, USA) at a crosshead
velocity of 0.6mm/min with a 1000N load cell was used. At
least 5 specimens of each scaffoldwere prepared in cylindrical
shape each with a 10mm diameter and 5mm height. From
the initial linear region of the plotted stress-strain curve, the
compressive modulus was calculated for each scaffold. For
each group of scaffolds, five samples were evaluated and the
results are presented as a mean ± SD.
2.2.5. In Vitro Bioactivity Testing. In vitro bioactivity assess-
ment were accomplished using standard SBF following the
method described by Kokubo and Takadama [20]. The
SBF solution was prepared through dissolving particular
amounts of NaCl, KCl, CaCl
2
, NaHCO
3
, K
2
HPO
4
⋅3H
2
O,
MgCl
2
⋅6H
2
O, andNa
2
SO
4
into deionized water.The solution
was adjusted to reach a pH 7.3-7.4 by altering the amount
of Tris buffer and 1.0M-HCl [20]. Scaffolds were cut to thin
slices with a diameter of 10mm and height of 3mm. These
scaffolds were then immersed in 50mL of prepared standard
SBF in centrifuge tubes at 37∘C incubated water bath for 14
and 21 days.The SBF solution was refreshed once a week until
completion.The PCL/R-SBgC composite in contact with SBF
was then analyzed using a FESEM and an EDX to determine
the presence of Ca-P phase’s formation on the surface of the
composite scaffold.
3. Result and Discussion
3.1. R-SBgC Powder. Figure 3 illustrates the FESEM image
and EDX spectrum of the synthesized R-SBgC powder prior
to being added into the scaffoldmixture.The FESEM analysis
of the R-SBgC powder confirmed the formation of spherical
agglomerated particles with diameter ranging from 64 to
300 nm with a mean diameter of 120 nm via randomly
measuring particle size at 25 different locations. The EDX
spectrum (Figure 3(b)) confirmed the presence of Si, Ca, and
Na as the main elements of the R-SBgC composition.
3.2. Fabrication of the 3D Porous Composite Scaffold. This
study demonstrated that a 3D highly porous structure of
PCL/R-SBgC composite scaffold can be produced using TIPS
technique. It is said that porosity can be controlled by
altering polymer content, polymer concentration, and solvent
concentration as well as other additive phase parameters [21].
In this study different concentrations of PCL including 5,
6.6 and 10% (w/v) were tested; the optimized concentration
of PCL 6.6% (w/v) was chosen because it produced the best
porosity up to 80% in thematerial. Based on previous reports,
it is believed that homogenous distribution of bioactive
ceramics (bioactive glass) in polymer solution and in scaffold
has direct effects on the bioactivity andmechanical properties
of scaffolds [12, 22]. This may be due to the higher con-
centration of doped bioactive glass, which tends to obstruct
the pores [12, 13]. In this study, R-SBgC in 10%, 20%, and
maximum 30% (w/w) were incorporated to the scaffold and
homogenized to achieve fine distribution in polymer matrix.
According to the literature, the use of R-SBgC nanoparticles
is supposed to be useful for further in vitro tests because of
its high surface area to volume ratio, which is said to enhance
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Figure 3: FESEMmicrographs of R-SBgC in magnification 25K X; marker 100 nm (a) and an EDAX spectrum of R-SBgC nanopowder (b).
(a)
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Figure 4: SEMmicrographs of the porous structure of scaffolds weremade using the 6.6% (w/v) PCL polymer solution. (a) Pure PCL scaffold,
(b) 30%R-SBgC/PCL scaffold in magnification 500x; marker 200 𝜇m. A higher magnification image (2K X) in upper right section of (b)
illustrates an aggregate trapped in the porosity including nanoparticles of R-SBgC powder.
cell adhesion [23]. The physical appearance of the composite
scaffold fabricated by TIPS technique can be seen in Figure 2.
This figure illustrates the homogeneity and proper size of
the fabricated scaffolds, which could be handled and carried
without difficulty.
3.3. Characterization
3.3.1. SEM Micrographs, FESEM, and EDX Analysis prior to
Bioactivity Testing. SEM micrographs reveal porous struc-
tures within the surfaces and inner structures of the fab-
ricated scaffolds. SEM images of pure PCL scaffold and
30% (w/w)R-SBgC/PCL composites are presented in Figure 4
as representatives of minimum and maximum R-SBgC con-
tent scaffolds.Themorphologies of the pure PCL scaffold and
composite present a typical microstructure of Polymeric scaf-
fold prepared using TIPS technique [23]. Furthermore, the
fabricated composite scaffold in this study showed an average
pore size of 100 𝜇m with interconnected porous structure
which is deemed suitable for cell migration and penetration
[24]. In Figures 4(a) and 4(b), the pore size appears to be
reduced with increasing amount of R-SBgC. El-Kady et al.
also report that the increase in the glass content from 25wt%
to 50wt% resulted in a decrease of composite scaffold pore
size [13]. This appears to be supported by other studies [13,
25]. Another explanation for the reduction in pore size may
be the decrease in solvent volume relative to the total weight
of the polymer and bioactive glass nanoparticles during the
preparation of the composites [12]. In addition to reduced
pore sizes, there appears to be increased agglomeration clus-
ter formation with increasing R-SBgC concentration. This is
especially evident in composites of 30%R-SBgC doped scaf-
fold (Figure 4(b)). Although most of the R-SBgC nanoparti-
cles are distributed homogeneously on the pore walls of the
scaffolds, some aggregates of nanoparticles are detectible in
some pores of the scaffold as observed in higher magnifica-
tion (2K X) in Figure 4(b). The presence of R-SBgC particles
was confirmed by the EDX data as presented in Figure 5.
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Table 1: Density porosity, pore size, and compressive modulus of R-SBgC/PCL composite scaffolds.
Scaffold % (w/w) Density∗ (g/cm3) Porosity∗ (%) Average pore sizes (𝜇m) Compressive modules∗ (MPa)
0% R-SBgC/PCL 0.062 ± 0.01 80 ± 0.03 105 0.375 ± 0.02
10% R-SBgC/PCL 0.078 ± 0.05 78 ± 0.02 102 0.411 ± 0.06
20% R-SBgC/PCL 0.101 ± 0.01 77 ± 0.03 100 0.442 ± 0.07
30% R-SBgC/PCL 0.163 ± 0.06 76 ± 0.04 98 0.475 ± 0.04
∗Mean ± standard deviation; 𝑛 = 5.
1 2 3 4
Si
Ca
CaCa
C
O
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Figure 5: An EDX spectrum confirming the presence of R-SBgC
particles in 20%R-SBgC/PCL composite scaffold.
3.3.2. Scaffold’s Density and Porosity. The porosity and den-
sity results of this study are summarized in Table 1. These
findings appear to be in linewith that of the SEMobservation.
It was found that by increasing R-SBgC concentration, the
porosity in the scaffold is maintained but with reduced
pore sizes. The degree of porosity percentage decreased
with the increase in R-SBgC concentration from 10% to
30% (w/w). Porosity of materials varies from 80% to 76%
for pure polymer and 30% (w/w) R-SBgC/PCL scaffolds
respectively. Findings from studies such asHong et al. appears
to support our findings [12]. The average pore sizes in the
testedmaterials ranged between 98 and 105𝜇mdepending on
the R-SBgC concentration. These sizes appear to be what is
recommended for bone tissue engineering purposes [21, 24].
3.3.3. Compression Test. The enhancement of the mechanical
performance due to the introduction of inorganic nanopar-
ticles in composites has been intensively discussed in pre-
vious studies [12, 21, 26]. Hong et al. [12] reported that
mechanical properties of PLLA matrix can be improved by
adding bioglass ceramic (BGC) nanoparticles. Similarly, the
improvement in the elastic modulus in the present material
was supported by data presented elsewhere [23]. It has been
previously suggested that the addition of HA or bioactive
glasses nanoparticles enhances the fortification of the scaffold
material which is seen as the increase in structural strength
[21, 26]. Increasing the R-SBgC concentration increases the
compressive modulus of the composite scaffolds (Table 1).
Scaffold with 30%R-SBgC/PCL showed a higher resistance to
compressive deformation compared to scaffold made of pure
PCL (Figure 7).The initial slope of the stress-strain curve was
used to obtain the compressive modulus of scaffolds. This
method was similar to that used in other studies [21]. Totally,
26.6% increase in the compressive modulus was observed
when 30%R-SBgC was incorporated into the pure PCL
scaffold (Table 1). The compressive modulus increased from
0.375Mpa to 0.475MPa when the R-SBgC concentration
increased from 0% to 30% (w/w), respectively. This was an
increase compared to a previous published report which
demonstrated a compressive strength increase from 0.28 to
0.35MPa as the BGC content increased from 0 to 30wt.%.
[12].
3.3.4. Capillarity Test. To investigate the pores interconnec-
tion of composite scaffold, capillarity test was carried out
on 30%R-SBgC/PCL composite scaffold which is supposed
to have smaller pore size and some more blocking site by
R-SBgC particles. The sequence of events can be seen in
photographs presented in Figure 8 showing clear infiltration
of the colored liquid through the porous network of the
composite scaffold. The colored fluid appeared to escalate
upwards in the scaffold within seconds, thus indicating the
porosity with possible interconnectivity within this material.
This finding was similar to those demonstrated in other
porous scaffold structures reported previously [27].
3.3.5. In Vitro Bioactivity Evaluation. The bioactivity eval-
uation of composite scaffolds was performed via SBF test.
This involved the immersion of the tested materials in SBF
for up to 21 days. The evaluation of bioactivity involves the
use of SEM and EDX as shown in Figures 6(a)–6(h). The
SEM micrographs revealed that all R-SBgC that included
scaffolds induced the microsized apatite formation after SBF
immersion.This findingwas supported by the EDXdata. Pure
PCL scaffold illustrated no major change in 14 and 21 days;
however, by 14 days, a small amount of NaCl precipitation
on the surfaces of scaffold could be observed and proved
by EDX data (Figure 6(a)). Analysis of samples after 21 days
immersion showed low intensity peaks of CaCl
2
and NaCl,
which can be recognized by the tiny distributed light spots
under SEM (Figure 6(b)). This finding was proved by EDX
data as well. The unknown peak of EDX micrographs is
related to Au coating for sample preparation before using
SEM. Results for 10% (w/w) R-SBgC/PCL scaffold after 14
days revealed precipitation of Ca, P, Na, Cl, and Si as
shown in Figure 6(c). EDX results confirmed the presence
of Si as one of the main components of R-SBgC powder,
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Figure 6: SEMmicrographs and EDX spectra illustrating the change on the surface of the scaffolds after 14 and 21 days (left and right columns
illustrate the images for 14 and 21 days, resp.) immersion in SBF (a-b) pure PCL scaffold (c-d) 10% (w/w) R-SBgC/PCL composite scaffold
and (e-f) 20% R-SBgC/PCL scaffold and (g-h) 30% R-SBgC/PCL scaffold in magnification 1000x; marker 10 𝜇m. The image in upper left of
section (h) illustrates the small HA crystals with needles like structure on the surface of scaffold in higher magnification (10K X).
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Figure 7: Compressive properties of PCL and R-SBgC/PCL scaffolds. (a) Typical compressive stress/strain curves of PCL, (b) compressive
module of 30% (w/w) R-SBgC/PCL composite scaffold.
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Figure 8: (a)–(c) phases of the capillarity test carried out on R-SBgC/PCL composite scaffold.
whilst the precipitation of Ca and P were related to HA
formation. By 21 days immersion, a considerable amount of
Ca was precipitated as the dominant phase in comparison
with P according to EDX micrograph and data illustrated in
Figure 6(d). The 20% (w/w) R-SBgC/PCL scaffold demon-
strated precipitation of Ca, P, Na, CL, and Si simultaneously
by 14 days of SBF immersion (Figure 6(e)). An increasing
amount of Ca and P precipitation in the form of HA clusters
was revealed after 21 days of SBF immersion as illustrated
in Figure 6(f). SEM and EDX analyses after immersion in
SBF demonstrated significant changes in the 30% (w/w) R-
SBgC/PCL scaffold as shown in Figures 6(g) and 6(h).The
scaffold surfaces were fully covered by Ca and P precipitation
by 14 and 21 days indicating HA formation. For 30% (w/w) R-
SBgC/PCL scaffold, the CaCl
2
precipitation was significantly
reduced and increased peaks of Ca and P were revealed after
21 days as illustrated in Figure 6(h). An increase in Ca and
P with reduced Si indicates the presence of apatite formation
according to previous research findings by Liu et al. [28]. SEM
micrograph with higher magnification (10K X), as shown
in upper left part of Figure 6(h), demonstrated small HA
crystals appearing as needles-like structures on the scaffold
surface. The Ca/P ratio was calculated using the EDX data
from different samples and sites and it provided ratio values
of Ca/P of between 1.57 and 2.6 indicating that the dominant
phase of the tested material contains nonstoichiometric
HA (Ca
10
(PO
4
)
6
(OH)
2
). Hydroxy apatite was the dominant
phase for samples with 1.6 Ca/P ratio. However, for scaffolds
with 2.0 and 2.5 Ca/P ratios, the CaO phase started to become
visible in the HA phase [29].The difference can be associated
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with the biphasic calcium phosphate structure formation
where 𝛽-TCP and HA phases were present [28]. Ca/P ratio
of 2.53. and 2.32 was recorded for 30% (w/w) R-SBgC/PCL
scaffold for 14 and 21 days, respectively. According to previous
in vitro study report, the osteoblast cells adhesion on calcium
phosphates with higher Ca/P ratios up to 2.5 was increased
significantly [28].
According to Hong et al., the formation of bone-like
apatite on PLLA/(30wt.%) bioactive glass ceramic (BGC)
composite is at a slower rate than PLLA/(20wt.%) BGC
composite. This may be attributed to the overloading of
BGC in the composite [12]. Conversely, according to findings
in this study, the 30% (w/w) R-SBgC/PCL scaffold revealed
better bioactivity results in comparison to 20% (w/w) R-
SBgC/PCL scaffold which is probably related to homoge-
nous distribution of R-SBgC particles and less agglomerated
clusters in the fabricated scaffolds in this study. This finding
indicates that the high content of R-SBgC addition up to
30% does not adversely influence the bioactivity of composite
scaffold.
4. Conclusions
Thehighly porous composite scaffolds based on R-SBgC/PCL
in this study were fabricated using TIPS technique. R-SBgC
particles were successfully incorporated into the compos-
ite scaffold providing interconnected porous structures of
approximately 80% and an average pore size of 100 𝜇m. In
vitro test showed the formation of HA on the surface of
the scaffold, with the highest formation of HA observed in
30% (w/w) R-SBgC/PCL composite scaffolds. The porosities,
densities, and pore sizes of the produced scaffolds varied with
R-SBgC concentrations.The interconnected pore structure of
the scaffold was indicated by means of capillarity test using
inked liquid. R-SBgC nanoparticles incorporated within the
scaffolding material improved the compressive mechanical
properties. However, in order for this material to be used
for bone tissue engineering, further studies investigating the
osteoconductive behavior need to be conducted. In addition,
other studies which may include material degradation rate,
cell growth and adhesion, biocompatibility, and material tox-
icity would need to be carried out in order to further establish
the material being produced as a potential biomaterial. The
present study proved that the use of rice husk, which is an
agricultural waste, in bioglass enhances PCL properties for
applications in bone tissue replacement.
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